Disparate outcomes in Hispanic patients with metabolic dysfunction-associated steatotic liver disease/steatohepatitis and type 2 diabetes: Large cohort study

doi:10.4239/wjd.v15.i5.886

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1159)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

WORD

HTML

841

Figures (1-3)

Tables (1-2)

Sum=1001

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=97

May 15, 2024 (publication date) through Jul 21, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Diabetes. May 15, 2024; 15(5): 886-897
Published online May 15, 2024. doi: 10.4239/wjd.v15.i5.886

Full Size Figure Download Figure

Figure 2 Patient demographic flow chart. The chart demonstrates the total number of metabolic dysfunction-associated steatohepatitis patients in both United States and University of Texas Medical Branch cohorts, total number of Hispanic/Latino and non-Hispanic/Latino patients in each cohort, the effects of Propensity Score Matching on cohort size, and the total number of male and female patients in each sub-cohort. MASH: Metabolic dysfunction-associated steatohepatitis; UTMB: University of Texas Medical Branch; HCO: Healthcare organizations.

Citation: Gosnell JM, Golovko G, Arroyave E, Moghe A, Kueht ML, Saldarriaga OA, McKinney KH, Stevenson HL, Ferguson MR. Disparate outcomes in Hispanic patients with metabolic dysfunction-associated steatotic liver disease/steatohepatitis and type 2 diabetes: Large cohort study. World J Diabetes 2024; 15(5): 886-897
URL: https://www.wjgnet.com/1948-9358/full/v15/i5/886.htm
DOI: https://dx.doi.org/10.4239/wjd.v15.i5.886